SARS‐CoV‐2 spike spurs intestinal inflammation via VEGF production in enterocytes

FM Zeng, Y Li, Z Deng, J He, W Li, L Wang… - EMBO Molecular …, 2022 - embopress.org
Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) can cause
gastrointestinal (GI) symptoms that often correlate with the severity of COVID‐19. Here, we …

Can Probiotics, Particularly Limosilactobacillus fermentum UCO-979C and Lacticaseibacillus rhamnosus UCO-25A, Be Preventive Alternatives against SARS-CoV-2 …

H Valdebenito-Navarrete, V Fuentes-Barrera, CT Smith… - Biology, 2023 - mdpi.com
Simple Summary Infection with the SARS-CoV-2 virus causes COVID-19 in humans. It has
rapidly propagated worldwide, becoming a pandemic as designated by the WHO. SARS …

Both Feline Coronavirus Serotypes 1 and 2 Infected Domestic Cats Develop Cross-Reactive Antibodies to SARS-CoV-2 Receptor Binding Domain: Its Implication to …

JK Yamamoto, LK Edison, DK Rowe-Haas, T Takano… - Viruses, 2023 - mdpi.com
The current study was initiated when our specific-pathogen-free laboratory toms developed
unexpectedly high levels of cross-reactive antibodies to human SARS-CoV-2 (SCoV2) …

Delving into revolutionary SARS-CoV-2 vaccine approaches: Molecular and virological examinations; principles of SARS-CoV-2 vaccine platform

F Edalat, FH Tabatabaie, A Moattari, A Letafati… - Vacunas (English …, 2024 - Elsevier
Abstract Coronavirus disease (COVID-19) is an infectious illness caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). It emerged in 2019 and quickly became …

[HTML][HTML] Revealing patterns of SARS-CoV-2 variant emergence and evolution using RBD amplicon sequencing of wastewater

X Chen, J Balliew, CX Bauer, J Deegan, A Gitter… - Journal of Infection, 2024 - Elsevier
Objectives Rapid evolution of SARS-CoV-2 has resulted in the emergence of numerous
variants, posing significant challenges to public health surveillance. Clinical genome …

Efficient Expression in Leishmania tarentolae (LEXSY) of the Receptor-Binding Domain of the SARS-CoV-2 S-Protein and the Acetylcholine-Binding Protein from …

L Son, V Kost, V Maiorov, D Sukhov, P Arkhangelskaya… - Molecules, 2024 - mdpi.com
Leishmania tarentolae (LEXSY) system is an inexpensive and effective expression
approach for various research and medical purposes. The stated advantages of this system …

Amyloidogenesis of SARS-CoV-2 delta plus and omicron variants receptor-binding domain (RBD): impact of SUMO fusion tag

S Zargan, H Jalili, B Dabirmanesh, S Mesdaghinia… - Biotechnology …, 2024 - Springer
Abstract Purpose The RBD of SARS-CoV-2 mediates viral entry into host cells by binding to
the host receptor ACE2. SARS-CoV-2 infection is linked to various health issues resembling …

Feline coronavirus infection of domestic cats causes development of cross-reactive antibodies to SARS-CoV-2 receptor binding domain

JK Yamamoto, LK Edison, DK Rowe-Haas, T Takano… - bioRxiv, 2022 - biorxiv.org
The current study was initiated when our specific pathogen-free laboratory toms developed
unexpectedly high levels of cross-reactive antibodies to human SARS-CoV-2 (SCoV2) …

Unlocking the therapeutic potential of edible mushrooms: Ganoderma and their secondary metabolites as novel antiviral agents for combating COVID-19

SC Karunarathna, W Lu, N Patabedige… - New Zealand Journal …, 2024 - Taylor & Francis
The global COVID-19 pandemic, caused by SARS-CoV-2, has created an urgent need for
novel antiviral agents, as it has led to a devastating loss of lives worldwide. In response …

[HTML][HTML] Analysis of SARS-CoV-2 RBD mutations in Khuzestan Province, Iran-A retrospective study, 2021

M Beheshti, N Neisi, M Parsanahad, M Rasti… - Iranian Journal of …, 2023 - ijmm.ir
L ess than two months after identification of the first cases in Wuhan, SARS-CoV-2, the
responsible virus for the ongoing pandemic, was detected in Iran in February 2020 (1). To …